ArticleEvidence-based complementary and alternative medicine : eCAM2022

Exosomal miR-221-3p Derived from Bone Marrow Mesenchymal Stem Cells Alleviates Asthma Progression by Targeting FGF2 and Inhibiting the ERK1/2 Signaling Pathway.

Weike Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.